1. Home
  2. FC vs RXST Comparison

FC vs RXST Comparison

Compare FC & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Covey Company

FC

Franklin Covey Company

HOLD

Current Price

$24.37

Market Cap

267.7M

ML Signal

HOLD

Logo RxSight Inc.

RXST

RxSight Inc.

HOLD

Current Price

$5.09

Market Cap

300.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FC
RXST
Founded
1983
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
267.7M
300.5M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
FC
RXST
Price
$24.37
$5.09
Analyst Decision
Strong Buy
Hold
Analyst Count
2
10
Target Price
$26.00
$9.78
AVG Volume (30 Days)
68.7K
988.3K
Earning Date
04-01-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$267,067,000.00
$134,479,000.00
Revenue This Year
$3.15
N/A
Revenue Next Year
$4.04
$10.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.16
$4.48
52 Week High
$25.50
$13.65

Technical Indicators

Market Signals
Indicator
FC
RXST
Relative Strength Index (RSI) 60.18 49.35
Support Level $23.07 $4.48
Resistance Level $25.50 $7.60
Average True Range (ATR) 1.22 0.29
MACD -0.08 0.11
Stochastic Oscillator 65.83 76.26

Price Performance

Historical Comparison
FC
RXST

About FC Franklin Covey Company

Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division. The company derives revenue from providing training and consulting services and through the sale of books, audio media, and other related products. It has a business presence in Australia, New Zealand, China, Japan, the United Kingdom, Ireland, and Other countries.

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.

Share on Social Networks: